Indefinite Delivery Contract 36E79725D0058
- Not listed
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026. The contract will supply aripiprazole tablets in various package sizes to the VA,...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract to Solco Healthcare US LLC (UEI: JN2QZJD6PKM9) on April 21, 2025, with a ceiling value of $12.9 million. This contract provides an uninterrupted supply of Tadalafil Tablets to support multiple federal health care entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract...
- Mylan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on March 4, 2023, for the supply of clozapine tablets. This contract carries a ceiling value of $8,346,790.65 and operates under no set-aside provision. The ordering period commenced on March 4, 2023, and extends through March 3, 2024, with four additional one-year renewal options available, establishing a potential five-year period of performance...
- The Harvard Drug Group, L.L.C., doing business as Major Pharmaceuticals, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on December 10, 2024, to supply Lurasidone Hydrochloride tablets to federal healthcare systems. The contract carries a ceiling value of $10,056,938.10 and extends through December 9, 2026, with a base year ordering period from December 10, 2024, to December 9, 2025, followed by four one-year option...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor. The contract has a ceiling value of $3,872,662.02 and covers a base year from August 19, 2025 to August 18, 2026, with four one-year option periods. The contract is for the supply of four line items of Solifenacin Succinate tablets in 5mg and 10mg strengths, with 30-count and...
- Avkare LLC was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on June 23, 2025, with a ceiling value of $24.9 million and a period of performance from June 23, 2025, through June 22, 2026. The contract procures Mycophenolate Mofetil capsules and tablets, an immunosuppressant medication commonly used in organ transplantation and treatment of autoimmune conditions. The procurement is unrestricted with no small business...
- This indefinite delivery contract was awarded by the National Acquisition Center, a civilian agency under the Department of Veterans Affairs (VA), to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor. The contract covers the procurement of Benazepril HCL tablets in various dosages, with an estimated annual requirement ranging from 867 bottles of 5mg tablets to 10,258 bottles of 20mg tablets. The contract has a base period of one year from November 6,...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Blanket Purchase Agreement (BPA) to AbbVie US LLC for the supply of pharmaceutical products, specifically DUOPA and VYALEV medications, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract carries a ceiling value of $15 million with an award date of August 1, 2025, and an ultimate completion date of July 31, 2026. This BPA was issued without a set-aside designation,...
- The key products and services being delivered under this federal contract IDV award are Perphenazine tablets in four different dosage strengths (2mg, 4mg, 8mg, and 16mg). The contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. This single-award, indefinite delivery contract has a ceiling value of $1,260,190.52 and a period of...
- This federal contract IDV award from the Department of Veterans Affairs (VA) National Acquisition Center is for the procurement of Aprepitant Capsules. The single-award contract has a ceiling value of $12,857,810.85 and an ordering period from November 1, 2025 to October 31, 2026, with four one-year option periods. The prime contractor is Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract aims to provide an...
Solco Healthcare US LLC was awarded a single-award Indefinite Delivery Contract on February 1, 2026, by the VA National Acquisition Center, a civilian federal agency, to supply Aripiprazole Tablets across multiple dosage strengths (2mg, 5mg, 10mg, 15mg, 20mg, and 30mg). The contract carries a ceiling value of $5,954,889.35 and encompasses a base year ordering period from February 1, 2026, to January 31, 2027, with four optional one-year renewal periods extending through January 31, 2027. This procurement was conducted as a commercial item acquisition under Federal Acquisition Regulation Part 12, without set-asides, and will distribute pharmaceutical products through the VA and Department of Defense Pharmaceutical Prime Vendor Programs to support the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Products must be supplied in 30-count bottles with safety caps meeting specific dimensional specifications, utilizing unique National Drug Codes specific to the awardee's organization with the contractor's own labeling. The original solicitation (RFP 36E79725R0052) anticipated significant annual requirements varying by dosage strength, ranging from approximately 26,474 bottles for the 30mg formulation to 99,161 bottles for the 5mg formulation. Solco Healthcare's 2026 subcontract plan has been incorporated into the contract with an effective period of January 1, 2026, through December 31, 2026. This procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and reflects the government's need for a reliable, uninterrupted supply chain of this widely-used antipsychotic medication across multiple federal health care systems and agencies. The single-award structure ensures supply continuity while establishing a long-term partnership with an approved pharmaceutical manufacturer.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Add Subcontract Plan | $0 | 1/7/26 | |
| Not listed | Not listed | $0 | 9/18/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Aripiprazole Tablets | 36E79725R0052 | Department of Veterans Affairs National Acquisition Center | Pre-Solicitation 1/2 | 6/16/25, 3:47 PM | |
6505--Aripiprazole Tablets | 36E79725R0052 | Department of Veterans Affairs National Acquisition Center | Solicitation 2/2 | 7/2/25, 9:21 AM |